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INTRODUCTION
Hog cholera (HC) -also known as "classical swine fever" (3) -is an infectious viral disease of domestic and wild pigs caused by a pestivirus (hog cholera virus: HCV) (4) . Recently, based on new insights into the replication strategy and genome organisation of pestiviruses, these were allocated to the family Flaviviridae (earlier, pestiviruses were considered as belonging to the family Togaviridae) (7) . HC remains an important disease economically, particularly in countries with a high pig population density (1) . The spread of HCV strains of low and medium virulence, which cause atypical and subclinical forms of HC, underlines the significance of serological monitoring in the eradication of this disease (14) .
In accordance with the OIE International
Animal Health Code and European Community (EC) regulations (10), a country exporting swine or swine products is obliged to demonstrate freedom from HC on the basis of serological investigations.
In 1990, Poland implemented a system of obligatory serological screening for HCV antibodies. The primary objective of the present three-year study was to obtain further data on the seroprevalence of HC in Poland.
MATERIALS AND METHODS

Sera
In accordance with instructions issued by the Polish Ministry of Agriculture (Department of Veterinary Services), blood samples were collected from sows and boars kept on private farms. In 1990, tests were conducted on 17,545 field sera from all except one of the 49 provinces in Poland; in 1991, 21,378 sera from 47 provinces were tested and in 1992, 16, 555 sera from 46 provinces were tested. The sera were heatinactivated at 56°C for 30 min, and kept frozen at -20°C until testing. The quality of the serum samples varied, with regard to haemolysis and bacterial contamination.
Serology
Blocking enzyme-linked immunosorbent assay (ELISA) (5) was used for serological screening for HCV antibody. In view of the fact that antibodies against bovine virus diarrhoea virus (BVDV) had been identified in the Polish swine population (11), the neutralisation peroxidase-linked assay (NPLA) (6, 8) was used for the differentiation of BVDV and HCV antibodies.
Enzyme-linked immunosorbent assay
HCV antigen for coating microplates was produced using the method described by Have (5), with the modifications proposed by Dalsgaard and Overby (2) . The Alfort strain of HCV was used for production of antigen in PK15 cell cultures propagated in roller bottles. Cells were scraped with a rubber policeman and pelleted by centrifugation. The cell pellet was extracted in two volumes of 20 mM tris (pH 7.2), 1% Triton X-100, 0.5 mM ethylene diamine tetra-acetic acid (EDTA) by sonication. The extract was clarified at 5,000 g for 20 min, precipitated by ammonium sulphate at 40% saturation and resuspended in 20 mM tris (pH 7.2), 0.1% Triton X-100 and 0.5 mM EDTA.
Depending on the titre, the antigen was diluted from 1:800 to 1:2,000 in carbonate buffer (pH 9.6) and placed on microplates. Plates were coated for 18 h at room temperature. After washing the plates three times with washing buffer (phosphatebuffered saline: PBS) containing 0.05% Tween 20 (PBST), test sera (diluted 1:2 in PBST) were placed in appropriate wells and incubated for 18 h at 4°C. Subsequently, microplates were washed three times with PBST. Microplates were then incubated for 1 h at 37°C with rabbit anti-HCV serum diluted 1:100-1:200. The microplates were then washed three times with PBST.
The ability of the test sera to inhibit the reaction between antigen and rabbit anti-HCV serum was examined by reaction with peroxidase-labelled anti-rabbit immunoglobulin G (IgG). Microplates were incubated with this conjugate (diluted according to the recommendations of the manufacturer) at 37°C for 30 min. After washing three times, the reaction was visualised by incubating the microplates for 15 min at room temperature in the dark with a substrate solution containing 4.6 mM ortho-phenylene diamine, 9 mM H 2 0 2 in 38 mM citric acid and sodium phosphate buffer (pH 5). After 15 min, the reaction was stopped with 0.5 N sulphuric acid. Optical densities (OD) were then recorded at 492 nm using an ELISA reader. On each microplate, two wells with negative reference sera and two wells with strong positive reference sera were included as controls.
Any uncoated sites on microplates were blocked using several blocking agents (horse serum, 1% bovine serum albumin, and 2%, 5% and 10% solutions of defatted dry bovine milk) in preliminary trials. The authors have previously shown that to be highly sensitive and specific, ELISA requires no blocking agents for the serodiagnosis of HC (12) , and therefore such agents were not used.
Interpretation of the results
In accordance with the method described by Have (5), the antibody reactivity of the test sera was calculated as percentage inhibition (PI), where:
(OD negative reference -OD test serum) x 100 OD negative reference -OD strong positive reference.
In accordance with the recommendation of Have (5) and the results presented by Leforban and colleagues (9), the cut-off value for inhibition was established at 25%. Therefore, samples diluted 1:2 were considered positive if the PI was less than 25%.
(Since the completion of the present investigations, a slightly different method of calculating PI values, where:
(OD negative reference -OD test serum) x 100 OD negative reference has been adopted by the Standards Commission of the OIE.) BVDV reactions may reach as high as 50% inhibition in the ELISA (5,9). Therefore, sera giving PI values in the range of 25-50% were retested against HCV and BVDV. Testing was conducted by neutralisation assay in microplates, using a 1:25 dilution of the tested serum as the initial dilution, and results were read by NPLA (6) . Results were determined by comparison of the serum titres obtained. The tested sera were considered negative for HC if the titre with BVDV was higher than that obtained with HCV. Sera with PI higher than 50% were considered HCV-and BVDV-negative.
RESULTS
The results demonstrated that, in 1990, 71 serum samples (0.40%) had BVDV antibodies; all other samples (17,464 sera), were free from HCV and BVDV antibodies (Table I ).
In 1991, 21, 378 serum samples were tested. All sera were found to be free from HCV antibodies, but the prevalence of BVDV-positive sera increased to 385 (1.8%). In 1992, 16,555 serum samples were tested and again all sera were free from HCV antibodies, and 176 serum samples (1.06%) were BVDV-positive. Differences were found in BVDV seroprevalence between the different provinces. In some provinces, 5.0% of pigs tested were BVDV-seropositive, whereas in other provinces all tested samples were negative for BVDV. The comparative serology by NPLA of the sera inhibiting 25-50% of the signal usually provided a clear-cut result, showing either the absence of antibody against HCV or titres distinctly lower than the corresponding antibody titre against BVDV. 
DISCUSSION
The choice of cut-off value is essential with regard to the sensitivity and specificity of blocking ELISA. A high cut-off value will eliminate false-positive results, but will also decrease the sensitivity of the test, leading to a risk of obtaining false-negative results (9) . The cut-off value of 25% applied in these studies has been previously determined experimentally (5, 9) . Corresponding standards (positive and negative sera) prepared by the authors were used. The specificity and sensitivity of the ELISA technique used in the present study was also controlled by using a set of HCV-and BVDV-positive and HCV-and BVDV-negative sera obtained from the EC Liaison Laboratory for Classical Swine Fever in Hanover (Germany), as well as a similar set of sera supplied by the Station de Pathologie Porcine in Ploufragan (France). Preliminary investigations demonstrated the balance between the required sensitivity and the number of heterologous reactions which could be tolerated. Simultaneously, it was demonstrated that, because of frequent occurrence of antibodies to BVDV in swine populations, it is necessary, in addition, to use NPLA to test sera with a PI ranging from 25-50%, for antibodies against this heterologous pestivirus. This confirms the findings of a previous report (5) .
Prior to 1991, approximately two million doses of hog cholera vaccine were used annually for vaccination against this disease in Poland. A programme of vaccination was followed only in State farms and in farms where garbage feed was used, while it was forbidden to vaccinate pigs in private enterprises. Therefore, according to Ministry of Agriculture regulations, only swine serum samples from private farms were tested. This excluded the possibility of obtaining false-positive reactions due to the detection of any residual vaccine.
The breeding pig population on private farms in Poland totals approximately 15 million animals. Of these, approximately 20,000 pigs are tested annually for HC seroprevalence. This represents a far greater proportion than in other European countries such as Denmark where, from a total of approximately 16 million pigs, only 4,500 are tested for HCV antibodies each year (P. Have, personal communication, 1993).
BVDV seroprevalence in Poland may be compared with that in other HCV-free countries. For example, Holm-Jensen (6) demonstrated BVDV antibodies in 6.4% of 3,000 serum samples tested in Denmark. Surveys revealed that the prevalence of naturally-occurring antibodies to BVDV in breeding pigs in Australia, Germany, the Netherlands and Ireland ranged from 3% to 40% (6, 13) . The frequent occurrence of antibodies to BVDV in swine populations, observed by other authors and in this study, justifies the need for precise determination of the cut-off value of the immunoenzymatic method applied. These findings also lend support to the use of NPLA to clarify doubtful ELISA results.
The methods used in this study may also be used for indirect (serological) differential diagnosis of infection with BVDV in pigs which have signs resembling HC (13) .
CONCLUSIONS
The blocking ELISA, applied together with NPLA, enables accurate surveillance of large numbers of samples for HCV antibodies.
All swine sera tested during the study between 1990 and 1992 were found to be free from HCV antibodies.
The study showed a non-significant increase of BVDV seroprevalence in pigs in Poland. 
